Immune Boost Capital Appoints Dr. Sai Nandi to Head Impact Investment Fund Targeting Immune-Mediated Diseases
Veteran biotech investor to steer IBC’s impact fund targeting early-stage therapies, diagnostics, and technologies for immune disorders. LOS ANGELES, CA, UNITED STATES, April 8, 2026 /EINPresswire.com/ -- Immune Boost Capital (IBC), the newly …